With CD Genomics' extensive NGS solutions, drug developers can maximize the potential of their pipeline. Our DNA and RNA NGS capabilities facilitate a deeper understanding of the mechanism of action and associated resistance mechanisms of drug candidates, while also enabling exploration of rational drug combinations at a broad scale and competitive cost effectiveness. Each step from nucleic acid extraction and library preparation to sequencing is performed in an accredited laboratory. Results from our high quality and detailed NGS analysis data to drive the discovery and drug discovery process in many disease areas.
CD Genomics has been committed to providing NGS-based solutions to global pharmaceutical and biotechnology companies to advance disease development mechanisms and new drug discovery. It is always our hope that our pharmaceutical research solution services will help our customers gain deeper inspiration and insights related to pharmaceuticals. Our pharma research solutions mainly include whole genome sequencing, transcriptome sequencing, single cell RNA sequencing, single cell genome sequencing, epigenome sequencing and metagenomics sequencing services.
Whole genome sequencing (WGS) is an integrated approach to analyze the entire genome. Genomic information helps identify inherited diseases, characterize mutations that drive cancer progression, and track disease outbreaks. CD Genomics can provide you with high-throughput NGS-based whole genome sequencing services for accurate, ultra-fast analysis.
CD Genomics offers you NGS-based transcriptome analysis services ranging from analysis of differential gene expression to detection of variable splicing and unknown transcripts. Our transcriptome sequencing analysis services can help you maximize your potential in the biopharmaceutical field by actively promoting the use of transcriptome sequencing in disease mechanism research and drug development.
CD Genomics offers NGS-based single-cell RNA sequencing services to help researchers explore the unique biology of individual cells in complex tissues and understand the responses of cell populations and cell subpopulations to various time-dependent processes of changes in the physiological environment, such as differentiation, proliferation, and disease progression.
CD Genomics provides you with NGS-based tumor immune microenvironment analysis services that enable quantification of the relative infiltration of innate and adaptive immune cells (CD8+, CD4+, T cells, B cells, Treg cells, NK cells, macrophages, monocytes, neutrophils) by proprietary immune cell type-specific gene expression profiles.
With years of experience and high quality NGS sequencing technology, CD Genomics offers common NGS-based methods available for epigenetic analysis including Methyl-seq, ATAC-seq, ChIP-seq and RIP-seq. Epigenetic analysis studies may involve the study of changes in DNA methylation, DNA-protein interactions, chromatin accessibility, histone modifications, etc., with major applications in disease mechanism studies.
CD Genomics provides you NGS-based metagenomics sequencing services, including complete workflow solutions, from DNA isolation and sequencing to advanced bioinformatics analysis. The main applications of metagenomics sequencing in the pharmaceutical field are gut microbiome analysis, infectious disease mechanism research and monitoring, disease target discovery, and improving the drug discovery and development process.
DRUG-seq is an exceptionally powerful and versatile tool for high-throughput drug screening. Its capacity to deliver comprehensive and precise transcriptomic data from minimal cell quantities renders it indispensable in the early stages of drug discovery. By enabling the concurrent screening of hundreds of candidate compounds, DRUG-seq markedly accelerates the drug development process, thereby enhancing the efficiency and success rate of identifying promising therapeutic candidates.
We are convinced that CD Genomics is the partner you have been seeking for your pharma research. Our automated sequencing platform and dedicated team of experts guarantee the accuracy of sequencing and analysis results. If you are interested in the pharma research solutions offered by CD Genomics, please feel free to contact us.
CD Genomics is transforming biomedical potential into precision insights through seamless sequencing and advanced bioinformatics.
